Abstract

Background. In 2005, Ghana adopted artemisinin-based combination therapy (ACT) for primary treatment of falciparum malaria. A comprehensive study of the drug-resistance–associated mutations and their genetic lineages will lead to a better understanding of the evolution of antimalarial drug resistance in this region

    Similar works

    Full text

    thumbnail-image

    Available Versions